Neville Rodie & Shaw Inc. Sells 157 Shares of Cigna Group $CI

Neville Rodie & Shaw Inc. reduced its position in shares of Cigna Group (NYSE:CI) by 5.5% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,687 shares of the health services provider’s stock after selling 157 shares during the quarter. Neville Rodie & Shaw Inc.’s holdings in Cigna Group were worth $889,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Flaharty Asset Management LLC bought a new stake in Cigna Group during the 1st quarter valued at about $28,000. 1248 Management LLC purchased a new stake in shares of Cigna Group during the 1st quarter valued at about $29,000. Activest Wealth Management boosted its holdings in shares of Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider’s stock valued at $30,000 after acquiring an additional 72 shares during the last quarter. Saudi Central Bank purchased a new stake in shares of Cigna Group during the 1st quarter valued at about $36,000. Finally, Evermay Wealth Management LLC boosted its holdings in shares of Cigna Group by 58.6% during the 1st quarter. Evermay Wealth Management LLC now owns 111 shares of the health services provider’s stock valued at $37,000 after acquiring an additional 41 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors.

Cigna Group Stock Performance

CI opened at $302.71 on Friday. The company has a current ratio of 0.71, a quick ratio of 0.71 and a debt-to-equity ratio of 0.65. The company has a market cap of $80.80 billion, a price-to-earnings ratio of 16.52, a PEG ratio of 0.90 and a beta of 0.48. The company’s 50 day moving average is $295.47 and its 200 day moving average is $312.00. Cigna Group has a 12-month low of $256.89 and a 12-month high of $370.83.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.15 by $0.05. The company had revenue of $67.13 billion for the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a net margin of 1.92% and a return on equity of 18.80%. The firm’s revenue was up 11.0% compared to the same quarter last year. During the same quarter last year, the firm posted $6.72 earnings per share. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, equities research analysts predict that Cigna Group will post 29.77 EPS for the current year.

Cigna Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th will be issued a dividend of $1.51 per share. The ex-dividend date of this dividend is Thursday, September 4th. This represents a $6.04 annualized dividend and a yield of 2.0%. Cigna Group’s payout ratio is currently 32.97%.

Insiders Place Their Bets

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of Cigna Group stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the transaction, the insider owned 25,648 shares of the company’s stock, valued at $7,694,400. The trade was a 52.66% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 0.70% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Wall Street Zen raised shares of Cigna Group from a “hold” rating to a “buy” rating in a report on Saturday. Deutsche Bank Aktiengesellschaft set a $415.00 price target on shares of Cigna Group and gave the company a “buy” rating in a report on Tuesday, August 5th. Truist Financial set a $375.00 price target on shares of Cigna Group in a report on Tuesday, September 2nd. Robert W. Baird set a $372.00 price target on shares of Cigna Group in a report on Thursday, August 14th. Finally, TD Cowen raised shares of Cigna Group to a “strong-buy” rating in a report on Monday, June 23rd. Two analysts have rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and two have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Buy” and a consensus target price of $374.76.

Cigna Group Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.